ALOMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Alomide patents expire, and when can generic versions of Alomide launch?
Alomide is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ALOMIDE is lodoxamide tromethamine. One supplier is listed for this compound. Additional details are available on the lodoxamide tromethamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALOMIDE?
- What are the global sales for ALOMIDE?
- What is Average Wholesale Price for ALOMIDE?
Summary for ALOMIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 147 |
| Drug Prices: | Drug price information for ALOMIDE |
| What excipients (inactive ingredients) are in ALOMIDE? | ALOMIDE excipients list |
| DailyMed Link: | ALOMIDE at DailyMed |
Pharmacology for ALOMIDE
| Drug Class | Mast Cell Stabilizer |
| Physiological Effect | Decreased Histamine Release |
US Patents and Regulatory Information for ALOMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ALOMIDE | lodoxamide tromethamine | SOLUTION/DROPS;OPHTHALMIC | 020191-001 | Sep 23, 1993 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALOMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | ALOMIDE | lodoxamide tromethamine | SOLUTION/DROPS;OPHTHALMIC | 020191-001 | Sep 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
